183 related articles for article (PubMed ID: 8157722)
1. Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus.
Zhu J; Leon SP; Beggs AH; Busque L; Gilliland DG; Black PM
J Clin Endocrinol Metab; 1994 Apr; 78(4):922-7. PubMed ID: 8157722
[TBL] [Abstract][Full Text] [Related]
2. Human pituitary adenomas infrequently contain inactivation of retinoblastoma 1 gene and activation of cyclin dependent kinase 4 gene.
Honda S; Tanaka-Kosugi C; Yamada S; Sano T; Matsumoto T; Itakura M; Yoshimoto K
Endocr J; 2003 Jun; 50(3):309-18. PubMed ID: 12940460
[TBL] [Abstract][Full Text] [Related]
3. Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomas.
Kirsch M; Mörz M; Pinzer T; Schackert HK; Schackert G
Genes Chromosomes Cancer; 2009 Feb; 48(2):143-54. PubMed ID: 18973139
[TBL] [Abstract][Full Text] [Related]
4. Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker.
Bates AS; Farrell WE; Bicknell EJ; McNicol AM; Talbot AJ; Broome JC; Perrett CW; Thakker RV; Clayton RN
J Clin Endocrinol Metab; 1997 Mar; 82(3):818-24. PubMed ID: 9062489
[TBL] [Abstract][Full Text] [Related]
5. The MEN-1 gene is rarely down-regulated in pituitary adenomas.
Asa SL; Somers K; Ezzat S
J Clin Endocrinol Metab; 1998 Sep; 83(9):3210-2. PubMed ID: 9745428
[TBL] [Abstract][Full Text] [Related]
6. Human adrenocorticotropin-secreting pituitary adenomas show frequent loss of heterozygosity at the glucocorticoid receptor gene locus.
Huizenga NA; de Lange P; Koper JW; Clayton RN; Farrell WE; van der Lely AJ; Brinkmann AO; de Jong FH; Lamberts SW
J Clin Endocrinol Metab; 1998 Mar; 83(3):917-21. PubMed ID: 9506748
[TBL] [Abstract][Full Text] [Related]
7. Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island.
Simpson DJ; Hibberts NA; McNicol AM; Clayton RN; Farrell WE
Cancer Res; 2000 Mar; 60(5):1211-6. PubMed ID: 10728677
[TBL] [Abstract][Full Text] [Related]
8. Screening for MEN1 tumor suppressor gene mutations in sporadic pituitary tumors.
Evans CO; Brown MR; Parks JS; Oyesiku NM
J Endocrinol Invest; 2000 May; 23(5):304-9. PubMed ID: 10882148
[TBL] [Abstract][Full Text] [Related]
9. Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB.
Pei L; Melmed S; Scheithauer B; Kovacs K; Benedict WF; Prager D
Cancer Res; 1995 Apr; 55(8):1613-6. PubMed ID: 7712461
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity at 13q14 correlates with RB1 gene underexpression in human breast cancer.
Bièche I; Lidereau R
Mol Carcinog; 2000 Nov; 29(3):151-8. PubMed ID: 11108660
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of molecular genetic changes in sporadic invasive pituitary adenomas.
Nam DH; Song SY; Park K; Kim MH; Suh YL; Lee JI; Kim JS; Hong SC; Shin HJ; Park K; Eoh W; Kim JH
Exp Mol Med; 2001 Sep; 33(3):111-6. PubMed ID: 11642545
[TBL] [Abstract][Full Text] [Related]
12. A reappraisal of the Rb1 gene abnormalities in the diagnosis of parathyroid cancer.
Cetani F; Pardi E; Viacava P; Pollina GD; Fanelli G; Picone A; Borsari S; Gazzerro E; Miccoli P; Berti P; Pinchera A; Marcocci C
Clin Endocrinol (Oxf); 2004 Jan; 60(1):99-106. PubMed ID: 14678295
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity at the retinoblastoma locus in human pituitary tumors.
Woloschak M; Roberts JL; Post KD
Cancer; 1994 Jul; 74(2):693-6. PubMed ID: 8033049
[TBL] [Abstract][Full Text] [Related]
14. Infrequent mutations of p27Kip1 gene and trisomy 12 in a subset of human pituitary adenomas.
Tanaka C; Yoshimoto K; Yang P; Kimura T; Yamada S; Moritani M; Sano T; Itakura M
J Clin Endocrinol Metab; 1997 Sep; 82(9):3141-7. PubMed ID: 9284759
[TBL] [Abstract][Full Text] [Related]
15. Molecular screening of pituitary adenomas for gene mutations and rearrangements.
Herman V; Drazin NZ; Gonsky R; Melmed S
J Clin Endocrinol Metab; 1993 Jul; 77(1):50-5. PubMed ID: 8100831
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity and mutations are the major mechanisms of RB1 gene inactivation in Chinese with sporadic retinoblastoma.
Choy KW; Pang CP; Yu CB; Wong HL; Ng JS; Fan DS; Lo KW; Chai JT; Wang J; Fu W; Lam DS
Hum Mutat; 2002 Nov; 20(5):408. PubMed ID: 12402348
[TBL] [Abstract][Full Text] [Related]
17. The retinoblastoma gene in human pituitary tumors.
Cryns VL; Alexander JM; Klibanski A; Arnold A
J Clin Endocrinol Metab; 1993 Sep; 77(3):644-6. PubMed ID: 7690360
[TBL] [Abstract][Full Text] [Related]
18. Different patterns of allelic loss (loss of heterozygosity) in recurrent human pituitary tumors provide evidence for multiclonal origins.
Clayton RN; Pfeifer M; Atkinson AB; Belchetz P; Wass JA; Kyrodimou E; Vanderpump M; Simpson D; Bicknell J; Farrell WE
Clin Cancer Res; 2000 Oct; 6(10):3973-82. PubMed ID: 11051246
[TBL] [Abstract][Full Text] [Related]
19. Analysis of loss of heterozygosity on chromosome 11 and infrequent inactivation of the MEN1 gene in sporadic pituitary adenomas.
Tanaka C; Kimura T; Yang P; Moritani M; Yamaoka T; Yamada S; Sano T; Yoshimoto K; Itakura M
J Clin Endocrinol Metab; 1998 Aug; 83(8):2631-4. PubMed ID: 9709923
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide amplification and allelotyping of sporadic pituitary adenomas identify novel regions of genetic loss.
Simpson DJ; Bicknell EJ; Buch HN; Cutty SJ; Clayton RN; Farrell WE
Genes Chromosomes Cancer; 2003 Jul; 37(3):225-36. PubMed ID: 12759921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]